AS THE INTERNET has evolved over its 35-year lifespan, control over its most important services has gradually shifted from open source protocols maintained by non-profit communities to proprietary services operated by...

The new discipline of bioengineering is going to dramatically impact how we produce and consume our food. The petroleum era ushered in many of the marquee companies and manufacturing processes of our generation – names...

Bioengineering, once viewed primarily as an academic discipline, is growing up.

One of the hardest problems in any organization, whether a democratic government or a corporation, is figuring out how to strike a balance between short-term interests and long-term goals. For some companies — espe...

Much of Silicon Valley mythology is centered on the founder-as-hero narrative. But historically, scientific founders leading the charge for bio companies have been far less common. Developing new drugs is slow, risky, an...

Those of us obsessed with the stock market — or even just our retirement funds — often tune in to watch a parade of characters standing behind a makeshift dais with their company logo proudly displayed, cheer...

Much has been made of the looming shortage of physicians. But there’s one place where the shortage is being felt acutely, is talked about even less, and the effects will ripple far into the future: the founding of new...

Because biology is the result of evolution and not human development, bringing engineering principles to it is guaranteed to fail. Or so goes the argument behind the “Grove fallacy,” first invoked by drug industry ...

The greatest problem of health care in United States – the world leader in health inequality – isn’t actually about the quality of care. The greatest problem we have is access to care. According to the CDC, ...